Loading...

PHARMAID Pharmaids Pharmaceuticals Ltd Litigation, disputes or regulatory action Announcement

Phrm

PHRM

Pharmaids Pharmaceuticals Ltd

(PHARMAID)

2024 Announcement

Summary

Summary

Management Change

Promoter Reclassification

Divestment Completed

Share Transfer Window

AGM Notice Published

Open Offer Update

Open Offer Announcement

Appointment Announcement

Financial Results Published

CEO Resignation

Management Change

Open Offer Update

Open Offer Announcement

Open Offer Announcement

Open Offer Announcement

Open Offer Update

Open Offer Update

Open Offer Announcement

Corrigendum Issued

Postal Ballot Notice

Compliance Certificate

Management Change

Stake Sale Announcement

Board Meeting Outcome

Financial Results Published

Annual Compliance Report

Compliance Certificate

Management Change

Fair Disclosure Code Update

Postal Ballot Notice

Financial Results Published

Capital Increase

Management Change

Land Acquisition

Stake Acquisition

Open Offer Notice

Open Offer Announcement

Compliance Certificate

Open Offer Update

Open Offer Announcement

Share Purchase Agreement

Open Offer Announcement

Open Offer Announcement

Director Share Sale

Insider Trading Disclosure

Insider Trading Disclosure

Insider Sale Disclosure

Director's Share Sale

Director Share Sale

National GLP Certification

Insider Trading Disclosure

Director Share Sale

Insider Sale Disclosure

Insider Trading Disclosure

Insider Trading Disclosure

Financial Results Published

Price Movement Clarification

Stake Acquisition

Regulatory Compliance

Stake Acquisition

Promoter Demise

Loan Agreement Signed

AGM Announcement

Financial Results

New Appointment

Reclassification Approval

Resignation Announcement

Approval for Reclassification

Loan Agreement Intimation

Compliance Certificate Subm...

Acquisition Update

Disclosure of Equity Sale

Equity Shares Sale Disclosure

Acquisition Update

Financial Results Publication

Funds Deviation Confirmation

Management Changes

Change in Management

Compliance Report Submission

Compliance Certificate

Compliance Certificate

Certificate Received

Reclassification Applicatio...

Insider Share Acquisition

Acquisition Completion

Equity Shares Allotment

Acquisition Update

Financial Results Advertise...

Change in Control

Confirmation of Fund Utiliz...

Reclassification Request

Acquisition Update

Amendments to Memorandum of...

Acquisition Update

Promoter Reclassification R...

Corrigendum to Notice of EGM

Acquisition Update

Certificate under Reg. 74 (...

Newspaper Publication

Authorization for Purchase ...

Acquisition Approval

Preferential Issue

Amendment in MOA

Management Appointments

Adoption of New Line of Bus...

Allotment of Equity Shares

Equity Shares Sale Disclosure

Equity Share Sale

Disinvestment of Equity Shares

Related Party Transactions ...

Publication of Financial Re...

No deviation in use of funds

Pending Litigation

Compliance Certificate

Equity Shares Sale

Reclassification of Shareho...

Newspaper Advertisement

Revision of Statement

Resignation of Director

Management Changes

Asset Acquisitions

Asset Acquisitions

Preferential Issue of share...

Reclassification of Promote...

Reclassifications

Reclassification of Promoter

Reclassification

Promoter reclassification

External Links:

Data:

Mr. Shreedhara Shetty, a Non-Executive Director of Pharmaids Pharmaceuticals, has reported the sale of 29,229 equity shares, reducing his holding from 63,32,359 shares (17.96%) to 63,03,130 shares (17.87%).

AI Assistant

Pharmaids Pharmaceuticals Ltd

2024

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.